Cargando…

Minocycline Prevents the Development of Mechanical Allodynia in Mouse Models of Vincristine-Induced Peripheral Neuropathy

Vincristine is an antineoplastic substance that is part of many chemotherapy regimens, used especially for the treatment of a variety of pediatric cancers including leukemias and brain tumors. Unfortunately, many vincristine-treated patients develop peripheral neuropathy, a side effect characterized...

Descripción completa

Detalles Bibliográficos
Autores principales: Starobova, H., Mueller, A., Allavena, R., Lohman, R. J., Sweet, M. J., Vetter, I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610325/
https://www.ncbi.nlm.nih.gov/pubmed/31316337
http://dx.doi.org/10.3389/fnins.2019.00653
_version_ 1783432486438567936
author Starobova, H.
Mueller, A.
Allavena, R.
Lohman, R. J.
Sweet, M. J.
Vetter, I.
author_facet Starobova, H.
Mueller, A.
Allavena, R.
Lohman, R. J.
Sweet, M. J.
Vetter, I.
author_sort Starobova, H.
collection PubMed
description Vincristine is an antineoplastic substance that is part of many chemotherapy regimens, used especially for the treatment of a variety of pediatric cancers including leukemias and brain tumors. Unfortunately, many vincristine-treated patients develop peripheral neuropathy, a side effect characterized by sensory, motoric, and autonomic symptoms. The sensory symptoms include pain, in particular hypersensitivity to light touch, as well as loss of sensory discrimination to detect vibration and touch. The symptoms of vincristine-induced neuropathy are only poorly controlled by currently available analgesics and therefore often necessitate dose reductions or even cessation of treatment. The aim of this study was to identify new therapeutic targets for the treatment of vincristine-induced peripheral neuropathy (VIPN) by combining behavioral experiments, histology, and pharmacology after vincristine treatment. Local intraplantar injection of vincristine into the hind paw caused dose- and time-dependent mechanical hypersensitivity that developed into mechanical hyposensitivity at high doses, and lead to a pronounced, dose-dependent infiltration of immune cells at the site of injection. Importantly, administration of minocycline effectively prevented the development of mechanical hypersensitivity and infiltration of immune cells in mouse models of vincristine induce peripheral neuropathy (VIPN) based on intraperitoneal or intraplantar administration of vincristine. Similarly, Toll-like receptor 4 knockout mice showed diminished vincristine-induced mechanical hypersensitivity and immune cell infiltration, while treatment with the anti-inflammatory meloxicam had no effect. These results provide evidence for the involvement of Toll-like receptor 4 in the development of VIPN and suggest that minocycline and/or direct Toll-like receptor 4 antagonists may be an effective preventative treatment for patients receiving vincristine.
format Online
Article
Text
id pubmed-6610325
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-66103252019-07-17 Minocycline Prevents the Development of Mechanical Allodynia in Mouse Models of Vincristine-Induced Peripheral Neuropathy Starobova, H. Mueller, A. Allavena, R. Lohman, R. J. Sweet, M. J. Vetter, I. Front Neurosci Neuroscience Vincristine is an antineoplastic substance that is part of many chemotherapy regimens, used especially for the treatment of a variety of pediatric cancers including leukemias and brain tumors. Unfortunately, many vincristine-treated patients develop peripheral neuropathy, a side effect characterized by sensory, motoric, and autonomic symptoms. The sensory symptoms include pain, in particular hypersensitivity to light touch, as well as loss of sensory discrimination to detect vibration and touch. The symptoms of vincristine-induced neuropathy are only poorly controlled by currently available analgesics and therefore often necessitate dose reductions or even cessation of treatment. The aim of this study was to identify new therapeutic targets for the treatment of vincristine-induced peripheral neuropathy (VIPN) by combining behavioral experiments, histology, and pharmacology after vincristine treatment. Local intraplantar injection of vincristine into the hind paw caused dose- and time-dependent mechanical hypersensitivity that developed into mechanical hyposensitivity at high doses, and lead to a pronounced, dose-dependent infiltration of immune cells at the site of injection. Importantly, administration of minocycline effectively prevented the development of mechanical hypersensitivity and infiltration of immune cells in mouse models of vincristine induce peripheral neuropathy (VIPN) based on intraperitoneal or intraplantar administration of vincristine. Similarly, Toll-like receptor 4 knockout mice showed diminished vincristine-induced mechanical hypersensitivity and immune cell infiltration, while treatment with the anti-inflammatory meloxicam had no effect. These results provide evidence for the involvement of Toll-like receptor 4 in the development of VIPN and suggest that minocycline and/or direct Toll-like receptor 4 antagonists may be an effective preventative treatment for patients receiving vincristine. Frontiers Media S.A. 2019-06-27 /pmc/articles/PMC6610325/ /pubmed/31316337 http://dx.doi.org/10.3389/fnins.2019.00653 Text en Copyright © 2019 Starobova, Mueller, Allavena, Lohman, Sweet and Vetter. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Starobova, H.
Mueller, A.
Allavena, R.
Lohman, R. J.
Sweet, M. J.
Vetter, I.
Minocycline Prevents the Development of Mechanical Allodynia in Mouse Models of Vincristine-Induced Peripheral Neuropathy
title Minocycline Prevents the Development of Mechanical Allodynia in Mouse Models of Vincristine-Induced Peripheral Neuropathy
title_full Minocycline Prevents the Development of Mechanical Allodynia in Mouse Models of Vincristine-Induced Peripheral Neuropathy
title_fullStr Minocycline Prevents the Development of Mechanical Allodynia in Mouse Models of Vincristine-Induced Peripheral Neuropathy
title_full_unstemmed Minocycline Prevents the Development of Mechanical Allodynia in Mouse Models of Vincristine-Induced Peripheral Neuropathy
title_short Minocycline Prevents the Development of Mechanical Allodynia in Mouse Models of Vincristine-Induced Peripheral Neuropathy
title_sort minocycline prevents the development of mechanical allodynia in mouse models of vincristine-induced peripheral neuropathy
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610325/
https://www.ncbi.nlm.nih.gov/pubmed/31316337
http://dx.doi.org/10.3389/fnins.2019.00653
work_keys_str_mv AT starobovah minocyclinepreventsthedevelopmentofmechanicalallodyniainmousemodelsofvincristineinducedperipheralneuropathy
AT muellera minocyclinepreventsthedevelopmentofmechanicalallodyniainmousemodelsofvincristineinducedperipheralneuropathy
AT allavenar minocyclinepreventsthedevelopmentofmechanicalallodyniainmousemodelsofvincristineinducedperipheralneuropathy
AT lohmanrj minocyclinepreventsthedevelopmentofmechanicalallodyniainmousemodelsofvincristineinducedperipheralneuropathy
AT sweetmj minocyclinepreventsthedevelopmentofmechanicalallodyniainmousemodelsofvincristineinducedperipheralneuropathy
AT vetteri minocyclinepreventsthedevelopmentofmechanicalallodyniainmousemodelsofvincristineinducedperipheralneuropathy